FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917869609> ?p ?o ?g. }

• W2917869609 abstract "Since lifestyle changes are main therapies for non-alcoholic fatty liver disease (NAFLD), changing dietary components (nutritional or bioactive) may play a parallel important role. Few studies have assessed the effects of curcumin on NAFLD (mainly antioxidant and anti-inflammatory effects). We aimed to determine the effects of nano-curcumin (NC) on overweight/obese NAFLD patients by assessing glucose, lipids, inflammation, insulin resistance, and liver function indices, especially through nesfatin.This double-blind, randomized, placebo-controlled clinical trial was conducted in the Oil Company Central Hospital, Tehran. 84 overweight/obese patients with NAFLD diagnosed using ultrasonography were recruited according to the eligibility criteria (age 25-50 yrs., body mass index [BMI] 25-35 kg/m2). The patients were randomly divided into two equal NC (n = 42) and placebo (n = 42) groups. Interventions were two 40 mg capsules/day after meals for 3 months. Lifestyle changes were advised. A general questionnaire, a 24-h food recall (at the beginning, middle and end), and the short-form international physical activity questionnaire (at the beginning and end) were completed. Also, blood pressure, fatty liver degree, anthropometrics, fasting blood sugar (FBS) and insulin (FBI), glycated hemoglobin (HbA1c), homeostasis model assessment-insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), tumor necrosis factor-alpha (TNF-α), high sensitive c-reactive protein (hs-CRP), interleukin-6 (IL-6), liver transaminases, and nesfatin were determined at the beginning and end.NC compared with placebo significantly increased HDL, QUICKI, and nesfatin and decreased fatty liver degree, liver transaminases, waist circumference (WC), FBS, FBI, HbA1c, TG, TC, LDL, HOMA-IR, TNF-α, hs-CRP, and IL-6 (P < 0.05). The mean changes in weight, BMI, body composition (BC), and blood pressure were not significant (P > 0.05). After adjustment for confounders, the changes were similar to the unadjusted model.NC supplementation in overweight/obese NAFLD patients improved glucose indices, lipids, inflammation, WC, nesfatin, liver transaminases, and fatty liver degree. Accordingly, the proposed mechanism for ameliorating NAFLD with NC was approved by the increased serum nesfatin and likely consequent improvements in inflammation, lipids, and glucose profile. Further trials of nano-curcumin's effects are suggested.Iranian Registry of Clinical Trials, IRCT2016071915536N3. Registered 2016-08-02." @default.
• W2917869609 created "2019-03-02" @default.
• W2917869609 creator A5005232665 @default.
• W2917869609 creator A5032672163 @default.
• W2917869609 creator A5041225233 @default.
• W2917869609 creator A5044936149 @default.
• W2917869609 creator A5064314322 @default.
• W2917869609 creator A5076860794 @default.
• W2917869609 creator A5090020095 @default.
• W2917869609 date "2019-01-28" @default.
• W2917869609 modified "2023-10-05" @default.
• W2917869609 title "Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial" @default.
• W2917869609 cites W1597960787 @default.
• W2917869609 cites W1651866740 @default.
• W2917869609 cites W1779585024 @default.
• W2917869609 cites W1930004935 @default.
• W2917869609 cites W1937364107 @default.
• W2917869609 cites W1975591344 @default.
• W2917869609 cites W1985900911 @default.
• W2917869609 cites W1987590050 @default.
• W2917869609 cites W1988327235 @default.
• W2917869609 cites W1990053893 @default.
• W2917869609 cites W1991128036 @default.
• W2917869609 cites W1993028853 @default.
• W2917869609 cites W1997149430 @default.
• W2917869609 cites W2004043239 @default.
• W2917869609 cites W2008059132 @default.
• W2917869609 cites W2008107953 @default.
• W2917869609 cites W2015175257 @default.
• W2917869609 cites W2015312906 @default.
• W2917869609 cites W2044264133 @default.
• W2917869609 cites W2046675462 @default.
• W2917869609 cites W2057758829 @default.
• W2917869609 cites W2060214284 @default.
• W2917869609 cites W2063671857 @default.
• W2917869609 cites W2070080324 @default.
• W2917869609 cites W2073266350 @default.
• W2917869609 cites W2077166822 @default.
• W2917869609 cites W2083999496 @default.
• W2917869609 cites W2098049360 @default.
• W2917869609 cites W2106842874 @default.
• W2917869609 cites W2108504295 @default.
• W2917869609 cites W2112622836 @default.
• W2917869609 cites W2115775861 @default.
• W2917869609 cites W2142914294 @default.
• W2917869609 cites W2154049977 @default.
• W2917869609 cites W2161234013 @default.
• W2917869609 cites W2306848376 @default.
• W2917869609 cites W2339666534 @default.
• W2917869609 cites W2409185764 @default.
• W2917869609 cites W2418580764 @default.
• W2917869609 cites W2469512664 @default.
• W2917869609 cites W2536607704 @default.
• W2917869609 cites W2547036892 @default.
• W2917869609 cites W2559816317 @default.
• W2917869609 cites W2560098666 @default.
• W2917869609 cites W2561224476 @default.
• W2917869609 cites W2568288029 @default.
• W2917869609 cites W2577850892 @default.
• W2917869609 cites W2584092725 @default.
• W2917869609 cites W2585491869 @default.
• W2917869609 cites W2608230138 @default.
• W2917869609 cites W2611686520 @default.
• W2917869609 cites W2617838815 @default.
• W2917869609 cites W2620079766 @default.
• W2917869609 cites W2622172314 @default.
• W2917869609 cites W2734363471 @default.
• W2917869609 cites W2755725463 @default.
• W2917869609 cites W2762357782 @default.
• W2917869609 cites W2765390123 @default.
• W2917869609 cites W2766083858 @default.
• W2917869609 cites W2767076259 @default.
• W2917869609 cites W2784083933 @default.
• W2917869609 cites W2893741876 @default.
• W2917869609 doi "https://doi.org/10.1186/s12986-019-0331-1" @default.
• W2917869609 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6348610" @default.
• W2917869609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30705687" @default.
• W2917869609 hasPublicationYear "2019" @default.
• W2917869609 type Work @default.
• W2917869609 sameAs 2917869609 @default.
• W2917869609 citedByCount "102" @default.
• W2917869609 countsByYear W29178696092019 @default.
• W2917869609 countsByYear W29178696092020 @default.
• W2917869609 countsByYear W29178696092021 @default.
• W2917869609 countsByYear W29178696092022 @default.
• W2917869609 countsByYear W29178696092023 @default.
• W2917869609 crossrefType "journal-article" @default.
• W2917869609 hasAuthorship W2917869609A5005232665 @default.
• W2917869609 hasAuthorship W2917869609A5032672163 @default.
• W2917869609 hasAuthorship W2917869609A5041225233 @default.
• W2917869609 hasAuthorship W2917869609A5044936149 @default.
• W2917869609 hasAuthorship W2917869609A5064314322 @default.
• W2917869609 hasAuthorship W2917869609A5076860794 @default.
• W2917869609 hasAuthorship W2917869609A5090020095 @default.
• W2917869609 hasBestOaLocation W29178696091 @default.
• W2917869609 hasConcept C126322002 @default.
• W2917869609 hasConcept C134018914 @default.
• W2917869609 hasConcept C142724271 @default.
• W2917869609 hasConcept C204787440 @default.
• W2917869609 hasConcept C27081682 @default.

• next